Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration (Q48345238)

From Wikidata

Revision as of 01:18, 5 July 2024 by KrBot (talk | contribs) (‎Set a claim value: title (P1476): Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published in November 1998

Language	Label	Description	Also known as
English	Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration	scientific article published in November 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9824689

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9824689

phosphorylation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Oh JD

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9824689

Russell DS

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9824689

Vaughan CL

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9824689

Chase TN

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9824689

language of work or name

0 references

publication date

1 November 1998

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9824689

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9824689

813

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9824689

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9824689

150-159

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9824689

Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Acute pharmacologic blockade of dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Prospects of glutamate antagonists in the therapy of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Reduction of tyrosine kinase activity and protein tyrosine dephosphorylation by anoxic stimulation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Neostriatal mechanisms in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Protein tyrosine kinase-mediated potentiation of currents from cloned NMDA receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

NMDA receptor blockade reverses motor response alterations induced by levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Effect of coadministration of glutamate receptor antagonists and dopaminergic agonists on locomotion in monoamine-depleted rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

The basal ganglia and adaptive motor control

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Protein tyrosine phosphorylation: implications for synaptic function

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Phosphorylation-dependent regulation of N-methyl-D-aspartate receptors by calmodulin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Problems with current pharmacologic treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Glutamatergic drugs in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Src activation in the induction of long-term potentiation in CA1 hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Reversal of parkinsonian symptoms in primates by antagonism of excitatory amino acid transmission: potential mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Fyn-kinase as a determinant of ethanol sensitivity: relation to NMDA-receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

The role of adenosine A2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Molecular neurobiology of drug addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

The current model of basal ganglia organization under scrutiny

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Glutamate receptor modulation by protein phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

NMDA receptor and the tyrosine phosphorylation of its 2B subunit in taste learning in the rat insular cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Long-term potentiation increases tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit 2B in rat dentate gyrus in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-D-aspartate receptor in long-term potentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Functional modulation of ligand-gated GABAA and NMDA receptor channels by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Neuronal circuitry and synaptic connectivity of the basal ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

NMDA receptor subunits epsilon 1 (NR2A) and epsilon 2 (NR2B) are substrates for Fyn in the postsynaptic density fraction isolated from the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Transient ischemia differentially increases tyrosine phosphorylation of NMDA receptor subunits 2A and 2B.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Regulation of NMDA receptors by tyrosine kinases and phosphatases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Tyrosine kinase inhibitors impair long-term memory formation in day-old chicks

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Effects of local connectivity on striatal function: stimulation and analysis of a model.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

NMDA channel regulation by channel-associated protein tyrosine kinase Src.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901049-X

7 January 2021

Identifiers

10.1016/S0006-8993(98)01049-X

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9824689

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/9824689

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48345238&oldid=2195658648"